 PITTSBURGH, Sept. 15, 2021 GLOBE NEWSWIRE -- Krystal Biotech, Inc., Krystal NASDAQ: KRYS, the leader in redosable gene therapies for rare diseases, today announced the appointment of Laurent Goux as the General Manager of Europe. Mr. Goux has more than 20 years of global biotechnology experience, including serving as the Head of Global Strategic Marketing and Market Access at Galderma. 